Montor-LC Tablet is a combination of Levocetirizine (5mg) and Montelukast (10mg) indicated for the treatment of chronic idiopathic urticaria, allergic rhinitis, and asthma. It is a potent and selective antagonist of the H1 receptor, exerting a prompt and sustained antihistaminic action, thereby reducing the severity and duration of symptoms associated with allergic rhinitis, such as sneezing, rhinitis, and pruritus. Additionally, Montelukast, a leukotriene receptor antagonist, effectively inhibits the synthesis of pro-inflammatory mediators, thereby preventing the constriction of airways, reducing bronchospasm, and improving lung function. The combination of these two active ingredients provides a synergistic effect, offering rapid and sustained relief from symptoms of chronic idiopathic urticaria, allergic rhinitis, and asthma. The tablet is to be taken once daily, with or without food, and should be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and administration instructions to ensure optimal therapeutic outcomes and minimize potential adverse reactions.